Skip to main content
驱动力 logo

驱动力 — Investor Relations & Filings

Ticker · 920275 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 479 across all filing types
Latest filing 2025-02-18 Share Issue/Capital Cha…
Country CN China
Listing Beijing Stock Exchange 920275

About 驱动力

https://www.chinaedrive.com/

Drive Power Bio-tech specializes in the research, development, and manufacturing of functional additives designed for animal nutrition. The company focuses on hematopoietic technology, providing solutions that enhance hemoglobin synthesis, strengthen immune responses, and support intestinal health. Its product portfolio includes specialized nutritional supplements that optimize metabolic processes and improve growth performance. By leveraging biotechnological innovation, the company develops high-efficiency additives aimed at enhancing physiological health and production efficiency in large-scale agricultural environments.

Recent filings

Filing Released Lang Actions
关于减少公司注册资本暨修订《公司章程》公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the reduction of the company's registered capital and the corresponding amendment to the company's articles of association. It details changes in share capital due to share repurchase and cancellation, and mentions submission to the shareholders' meeting and regulatory compliance. The content is about capital structure changes and corporate governance amendments, not a full financial report or earnings release. It is not a report publication announcement or a certification. The document fits best under 'Share Issue/Capital Change' (SHA) as it concerns changes in share capital and company registration capital.
2025-02-18 Chinese
关于变更回购股份用途并注销的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the change in the use of repurchased shares and their cancellation by Guangdong Drive Biological Technology Group Co., Ltd. It details the board meeting resolution, the repurchase plan, the number of shares to be cancelled, and the impact on share capital structure. The document does not contain financial statements or detailed financial data but is a formal disclosure of a corporate action related to share repurchase and cancellation. This fits the category of Transaction in Own Shares (POS), which covers announcements of share buybacks or cancellations.
2025-02-18 Chinese
关于公司再次通过高新技术企业认定的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Guangdong Drive Biological Technology Group Co., Ltd. about the company receiving a renewed High-Tech Enterprise Certificate. It discusses the tax benefits and the impact on the company but does not contain financial statements or detailed financial data. The document is short (725 characters) and serves as a formal notification of a regulatory or operational update rather than a financial report or detailed management discussion. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is also not a voting result, board change, or capital update. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-02-12 Chinese
关于取得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Guangdong Driving Force Biotechnology Group Co., Ltd. about obtaining two invention patent certificates issued by the National Intellectual Property Office. It details the patent names, numbers, application dates, and the impact of these patents on the company. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no shareholder meeting materials, or management changes. The document is a regulatory announcement about intellectual property achievements, which does not fit into financial report categories like Annual Report, Interim Report, or Earnings Release. It is also not related to capital changes, legal proceedings, or governance. Given the nature of the announcement and the absence of other fitting categories, the best classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories. The document length is short and it is a direct announcement, not a report publication announcement. Confidence is high due to clear content and context.
2025-02-06 Chinese
2024年年度业绩预告公告
Earnings Release Classification · 95% confidence The document is a performance forecast announcement for the fiscal year 2024, providing preliminary financial data and profit estimates. It explicitly states that the data is unaudited and subject to change in the final annual report. The document is short (946 characters) and serves as a notice of expected financial results rather than a full financial report. It does not contain detailed financial statements or comprehensive analysis. Therefore, it is best classified as an Earnings Release (ER), which covers initial announcements of quarterly or periodical financial results with key highlights only. FY 2024
2025-01-21 Chinese
第四届董事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the fifth meeting of the fourth board of directors of Guangdong Driving Force Biotechnology Group Co., Ltd. It details the meeting date, attendance, agenda items, and voting results. There is no financial data, audit information, or report publication mentioned. The content focuses on board meeting decisions and governance matters, specifically the approval of a company policy. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management.
2025-01-14 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.